01 1Aurobindo Pharma Limited
02 1Corden Pharma Colorado, Inc.
03 1F. Hoffmann-La Roche Ltd
04 1MAEDA INC
01 1GANCICLOVIR
02 3Ganciclovir
01 1Germany
02 1India
03 1Switzerland
04 1Blank
NDC Package Code : 59651-108
Start Marketing Date : 2024-01-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12869-803
Start Marketing Date : 2003-04-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12806-6941
Start Marketing Date : 1989-06-23
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (500mg/.01kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 86184-121
Start Marketing Date : 2024-05-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Zirgan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zirgan, including repackagers and relabelers. The FDA regulates Zirgan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zirgan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zirgan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zirgan supplier is an individual or a company that provides Zirgan active pharmaceutical ingredient (API) or Zirgan finished formulations upon request. The Zirgan suppliers may include Zirgan API manufacturers, exporters, distributors and traders.
click here to find a list of Zirgan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zirgan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zirgan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zirgan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zirgan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zirgan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zirgan suppliers with NDC on PharmaCompass.
We have 3 companies offering Zirgan
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
